Figure 2
From: Association of myosteatosis with short-term outcomes in patients with acute-on-chronic liver failure
The 90-day cumulative mortality in the groups with and without myosteatosis (A), and the groups with co-existing sarcopenia and myosteatosis in male patients with HBV-ACLF (B).
